A thymic-peptide immune stack pairing thymosin alpha-1 with thymalin for immune modulation.
Thymosin alpha-1 is the most clinically-studied immune-modulating peptide — used adjunctively in infection and immune-support settings — and anchors this stack. Thymalin (a thymic peptide extract) is added as a complementary immune-modulator.
These are run in courses rather than continuously. As immune-acting compounds, they're firmly in 'work with a clinician' territory for anyone with an actual immune condition; the stack is here to explain the mechanisms, not to prescribe.
| Compound | Role | Dose | Frequency |
|---|---|---|---|
| Thymosin Alpha 1 Most-studied immune-modulating peptide; run in courses. | Primary | 1.6mg per injection (standard dose across all protocols) | 2x weekly (e.g., Monday and Thursday) for standard immune support |
| Thymalin Thymic peptide; complementary immune modulation. | Support | 10mg per injection | Daily for 5-10 days, then break |